Conditions: Acne Vulgaris
Keywords: acne Botox cosmetic treatments
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 5
Healthy volunteers: no

Brief summary:
• To determine the safety and efficacy of Botox Treatment in subjects with mild to moderate acne vulgaris defined by the Investigator's Global Assessment (IGA)

Detailed description:
• 90 day trial, with botox being injected at baseline/screening visit. Photos will be taken throughout the study and patients will be evaluated by masked injector evaluator and a masked evaluator. Patient will complete a subject evaluation at each visit. Follow-up visits occur at Day 3, 7, 14, 30 and 90.

Arms:
arm 1: Botulinum Neurotoxin Type A (Botox, 1.5-3 units/lesion); Bacteriostatic saline solution (0.11 cc/lesion)

Interventions: intervention 1: Botulinum Neurotoxin Type A intervention 2: Bacteriostatic saline
Intervention descriptions: intervention 1: 1.5-3 units of Botox/lesion intervention 2: .1 cc bacteriostatic saline/lesion

Protocol document: